Cryoglobulinemia type 1
ICD-10 D89.1 · ICD-11 4B22.1

Treatment of Cryoglobulinemia Type 1 in Multiple Myeloma with Monoclonal IgG Cryoglobulin

Type I (simple monoclonal) cryoglobulinemia occurs when a single monoclonal immunoglobulin precipitates in the cold. When the cryoglobulin is of the IgG class, the underlying driver is most often multiple myeloma or MGUS — and identifying that malignancy is the central clinical priority.

Clinical scenario: A patient with type I cryoglobulinemia in whom the cryoglobulin is monoclonal IgG and the underlying condition is myeloma. Simple monoclonal cryoglobulinemia is associated with B-cell malignancies, including myeloma, and monoclonal IgG specifically points toward myeloma or MGUS as the source.

Treatment approach

In symptomatic type I cryoglobulinemia, the treatment strategy is directed at the underlying hematological malignancy — here, the myeloma. Myeloma-directed therapy forms the cornerstone of management. Avoidance of cold-temperature exposure is an important supportive recommendation. The complete regimen, sequencing, and full clinical algorithm are available in the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.jbspin.2019.01.016

Monoclonal IgM cryoglobulinemia suggests Waldenström macroglobulinemia or another type of lymphoma and monoclonal IgG cryoglobulinemia myeloma or MGUS.

Simple monoclonal (type I) cryoglobulinemia is associated with B-cell malignancies, notably Waldenström macroglobulinemia and myeloma, and with MGUS.

In patients with symptomatic cryoglobulinemia type I, the treatment strategy focuses on the underlying hematological malignancy.

Thus, lymphoma requires combination chemotherapy and myeloma treatment with drugs such as bortezomib, thalidomide, lenalidomide, or alkylating agents.

Exposure to low temperatures exacerbates cryoglobulin formation and should therefore be avoided.

View source ↗